Wu June K, Bisdorff Annouk, Gelbert Françoise, Enjolras Odile, Burrows Patricia E, Mulliken John B
Vascular Anomalies Center, Division of Plastic Surgery, and Department of Radiology, Children's Hospital, Harvard Medical School, Boston, Mass 02115, USA.
Plast Reconstr Surg. 2005 Apr;115(4):985-95. doi: 10.1097/01.prs.0000154207.87313.de.
The external ear is the second most common site for extracranial arteriovenous malformation in the head and neck.
This retrospective review of 41 patients with auricular arteriovenous malformation was based on medical records, imaging studies, and photographs. Data were collected on natural history, progression, and outcome; patients were questioned about quality of life after treatment.
The median age at initial presentation was 26 years (range, 1 to 55 years), and Schobinger stage was I in two patients, II in 19 patients, and III in 20 patients. No patients had a Schobinger stage of IV. Expansion occurred during childhood in seven patients, adolescence in 14 patients, pregnancy in 10 patients, and adulthood in 10 patients. Distribution of auricular and extra-auricular arteriovenous malformation was not limited to "watershed" areas between vascular territories (angiosomes). Twelve patients were untreated (follow-up, 0.5 to 6 years). Mean follow-up time for the 29 treated patients was 5.19 years (range, 1 to 18.75 years). Proximal ligation in nine patients caused progression: eight of them underwent amputation and one had embolization. Fifteen patients had embolization only: the arteriovenous malformation worsened and amputation was necessary in six patients; in the remaining nine patients, two improved, four persisted, and three worsened. Of 20 patients who had auricular amputation, 16 (80 percent) were controlled, three (15 percent) improved, and one had unresectable, residual cervicofacial arteriovenous malformation. Of 22 of 29 treated patients surveyed, 81 percent were satisfied with their management. Hearing was either unaffected (n = 15) or diminished (n = 5); two patients noted decreased sound localization.
The authors recommend periodic evaluation for stage I to II auricular arteriovenous malformation and intervention if there is evolution to stage III. Preoperative embolization and partial or total amputation effectively control auricular and para-auricular arteriovenous malformation. Embolization can be palliative in children or in patients who are not psychologically prepared for amputation. Extensive extra-auricular arteriovenous malformation requires individualized endovascular therapy and resection.
外耳是头颈部颅外动静脉畸形的第二常见部位。
本研究对41例耳廓动静脉畸形患者进行回顾性分析,依据病历、影像学检查及照片。收集自然病史、病情进展及治疗结果等数据;询问患者治疗后的生活质量。
初次就诊时的中位年龄为26岁(范围1至55岁),Schobinger分期:I期2例,II期19例,III期20例。无IV期患者。7例在儿童期病变扩大,14例在青春期,10例在孕期,10例在成年期。耳廓及耳外动静脉畸形的分布并不局限于血管区域(血管体)之间的“分水岭”区域。12例患者未接受治疗(随访0.5至6年)。29例接受治疗患者的平均随访时间为5.19年(范围1至18.75年)。9例行近端结扎的患者病情进展:其中8例接受截肢,1例接受栓塞治疗。15例仅接受栓塞治疗:6例动静脉畸形恶化需截肢;其余9例中,2例改善,4例维持原状,3例恶化。20例行耳廓截肢的患者中,16例(80%)病情得到控制,3例(15%)改善,1例有不可切除的残余颈面部动静脉畸形。在接受调查的29例接受治疗患者中的22例中,81%对其治疗效果满意。听力未受影响者15例,听力减退者5例;2例患者指出声音定位能力下降。
作者建议对I至II期耳廓动静脉畸形进行定期评估,若病变进展至III期则进行干预。术前栓塞及部分或全部截肢可有效控制耳廓及耳旁动静脉畸形。栓塞治疗对于儿童或未做好截肢心理准备的患者可起到姑息作用。广泛的耳外动静脉畸形需要个体化的血管内治疗及手术切除。